JESSICA SHANTZ: Open Payments
NPI 1790255248 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,617 in 162 payments from 16 companies in 2025. Trend: 2023 $5,310 · 2024 $3,291 · 2025 $3,617
Food & beverage: $3,598Travel & lodging: $10Education: $9
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $554 |
| Neurocrine BioSciences, Inc. | 23 | $412 |
| Otsuka America Pharmaceutical, Inc. | 14 | $411 |
| Alkermes, Inc. | 16 | $324 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $317 |
| Teva Pharmaceuticals USA, Inc. | 13 | $306 |
| E.R. Squibb & Sons, L.L.C. | 8 | $286 |
| Vanda Pharmaceuticals Inc. | 11 | $272 |
| ABBVIE INC. | 17 | $267 |
| Lundbeck LLC | 11 | $177 |
Products named: Auvelity, REXULTI, INGREZZA, CAPLYTA, ARISTADA, COBENFY, FANAPT, VRAYLAR.
Industry payments across MI — which companies pay providers there.
